These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34382555)

  • 1. COVID-19 vaccines - less obfuscation, more transparency and action.
    Venter WDF; Madhi SA; Nel J; Mendelson M; Van den Heever A; Moshabela M
    S Afr Med J; 2021 Apr; 111(6):515-516. PubMed ID: 34382555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A call to action: Temporal trends of COVID-19 deaths in the South African Muslim community.
    Omar MAK; Jassat W; Brey Z; Parker S; Wadee M; Wadee S; Madhi SA
    S Afr Med J; 2021 Jul; 111(9):13348. PubMed ID: 34949242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Critical Care Society of Southern Africa guidelines on the allocation of scarce critical care resources during the COVID-19 public health emergency in South Africa.
    Gopalan PD; Joubert IA; Paruk F; Baker D; Coetzee I; De Vasconcellos K; Dolo LM; Levy BL; Morrow BM; Nel JM; Omar S; Piercy JL; Siebert RS; Veldsman L; Singh JA; Moodley K
    S Afr Med J; 2020 Jun; 110(8):700-703. PubMed ID: 32880283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dial down the rhetoric over COVID-19 vaccines.
    Schoub BD
    S Afr Med J; 2021 Apr; 111(6):522-523. PubMed ID: 34382558
    [No Abstract]   [Full Text] [Related]  

  • 5. Barriers to the representation of researchers from developing countries in international health and potential strategies to address these.
    Haribhai S
    S Afr Med J; 2021 Mar; 111(3):13228. PubMed ID: 33944733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
    Irfan N; Chagla Z
    Ann Intern Med; 2021 May; 174(5):JC50. PubMed ID: 33939483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Privacy rights of human research participants in South Africa must be taken seriously.
    Thaldar DW; Townsend B; Staunton C; Adams R; Botes M; Dove ES; Horn L; Labuschaigne M; Loots G; Mahomed S; Olckers A; Pepper MS; Pope A; Ramsay M; Ni Loideain N; De Vries J
    S Afr Med J; 2020 Feb; 110(3):175-176. PubMed ID: 32657692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
    Gil M; Ramil F; AgÍs JA
    Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic research and privacy: A response to Staunton et al.
    Thaldar DW; Townsend B
    S Afr Med J; 2020 Feb; 110(3):172-174. PubMed ID: 32657691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d.
    Sacks HS
    Ann Intern Med; 2021 Jul; 174(7):JC75. PubMed ID: 34224270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Mar; 174(3):JC29. PubMed ID: 33646835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of harmful alcohol use in South Africa: A reply to Murray and Barr (2022).
    Matzopoulos R; Truen S; Bowman B; Corrigall J
    S Afr Med J; 2022 Jul; 112(7):451-452. PubMed ID: 36217853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. South Africa should be using all the COVID-19 vaccines available to it - urgently.
    Venter WDF; Madhi SA; Nel J; Mendelson M; Van den Heever A; Moshabela M
    S Afr Med J; 2021 Mar; 111(5):390-392. PubMed ID: 34852876
    [No Abstract]   [Full Text] [Related]  

  • 14. In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Mar; 174(3):JC28. PubMed ID: 33646836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Feb; 174(2):JC15. PubMed ID: 33524290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxford COVID-vaccine paper highlights lingering unknowns about results.
    Ledford H
    Nature; 2020 Dec; 588(7838):378-379. PubMed ID: 33293710
    [No Abstract]   [Full Text] [Related]  

  • 17. South Africa responds to new SARS-CoV-2 variant.
    Makoni M
    Lancet; 2021 Jan; 397(10271):267. PubMed ID: 33485437
    [No Abstract]   [Full Text] [Related]  

  • 18. The Novavax vaccine had 90% efficacy against COVID-19 ≥7 d after the second dose.
    Sacks HS
    Ann Intern Med; 2021 Nov; 174(11):JC124. PubMed ID: 34724399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The position of the National Department of Health regarding interpretation of violations of the Regulations Relating to Foodstuffs for Infants and Young Children (R991).
    Ntsie PR
    S Afr Med J; 2020 Mar; 110(4):12895. PubMed ID: 32657735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa.
    Gray G; Van der Heever A; Madhi S; McIntyre J; Kana B; Stevens W; Sanne I; Richards G; Abdullah F; Mendelson M; Dasoo A; Nel J; Wulfsohn A; Blumberg L; Venter F
    S Afr Med J; 2020 Dec; 111(2):89-94. PubMed ID: 33944712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.